Abstract: The present disclosure is concerned with borylated amidoximes useful in the synthesis of biologically relevant drug-like molecules, including functionalized oxadizole and quinazolinone derivatives. Also disclosed are methods of making borylated amidoximes, methods of making functionalized oxadiazole and quinazolinone compounds using the amidoximes, and functionalized oxadiazole and quinazolinone compounds prepared from borylated amidoximes. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
| # | Name | Date |
|---|---|---|
| 1 | 202417062146-STATEMENT OF UNDERTAKING (FORM 3) [16-08-2024(online)].pdf | 2024-08-16 |
| 2 | 202417062146-REQUEST FOR EXAMINATION (FORM-18) [16-08-2024(online)].pdf | 2024-08-16 |
| 3 | 202417062146-PROOF OF RIGHT [16-08-2024(online)].pdf | 2024-08-16 |
| 4 | 202417062146-PRIORITY DOCUMENTS [16-08-2024(online)].pdf | 2024-08-16 |
| 5 | 202417062146-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [16-08-2024(online)].pdf | 2024-08-16 |
| 6 | 202417062146-FORM FOR SMALL ENTITY(FORM-28) [16-08-2024(online)].pdf | 2024-08-16 |
| 7 | 202417062146-FORM 18 [16-08-2024(online)].pdf | 2024-08-16 |
| 8 | 202417062146-FORM 1 [16-08-2024(online)].pdf | 2024-08-16 |
| 9 | 202417062146-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [16-08-2024(online)].pdf | 2024-08-16 |
| 10 | 202417062146-DRAWINGS [16-08-2024(online)].pdf | 2024-08-16 |
| 11 | 202417062146-DECLARATION OF INVENTORSHIP (FORM 5) [16-08-2024(online)].pdf | 2024-08-16 |
| 12 | 202417062146-COMPLETE SPECIFICATION [16-08-2024(online)].pdf | 2024-08-16 |
| 13 | 202417062146-FORM-26 [18-11-2024(online)].pdf | 2024-11-18 |
| 14 | 202417062146-FORM 3 [31-01-2025(online)].pdf | 2025-01-31 |